Program
HSK47388
A development code.
Its studies are mostly in Colitis, Ulcerative · Psoriasis, led by Haisco Pharmaceutical Group.
Furthest: phase 2, since Aug 28, 20253 company-led studies, 3 open or runningNext primary completion: Dec 20, 2026 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Haisco Pharmaceutical Group | 33 open or running | phase 2since Aug 28, 2025 | Mar 27, 2025 | Dec 20, 2026phase 2 · NCT07158268 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 27, 2025First study: phase 1 study in HealthyFirst studyNCT06926218 · 40 planned · Australia
- Aug 28, 2025Phase 2 study in Plaque PsoriasisNCT07158268 · 220 planned
- Jan 4, 2026Phase 2 study in Colitis, UlcerativeNCT07335055 · 150 planned · China
Ahead
- Dec 20, 2026Primary completion: phase 2 study in Plaque PsoriasisNCT07158268
- Oct 15, 2027Primary completion: phase 2 study in Colitis, UlcerativeNCT07335055
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07335055Colitis, Ulcerative · China | 2 | Recruiting | Oct 15, 2027 | 150 |
| NCT07158268Plaque Psoriasis | 2 | Not yet recruiting | Dec 20, 2026 | 220 |
| NCT06926218Healthy · Australia | 1 | Not yet recruiting | Jul 2025 | 40 |
How it is read
Names in the registry
- “HSK47388”, 3 entries
Codes read as this program: HSK47388.
Conditions, from the studies’ own filings
- Colitis, Ulcerative, 1 study
- Psoriasis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.